Avid Bioservices, Inc.
CDMO · NASDAQ
4/30/2024 | 4/30/2023 | 4/30/2022 | 4/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.3% | 24.8% | 24.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 5.2% | 21.1% | 30.6% | 30.6% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -8.2% | 7.3% | 16.6% | 16.4% |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -100.6% | 0.4% | 106.8% | 11.7% |
| EPS Diluted | -2.23 | 0.009 | 1.81 | 0.056 |
| % Growth | -25,440.9% | -99.5% | 3,143.7% | – |
| Operating Cash Flow | $0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |